Evidence map›Paper›PMID 35515141›Full record

ReviewRSC advances2020

Synthesis and modification of ZIF-8 and its application in drug delivery and tumor therapy.

Qiuxiang Wang, Yue Sun, Shangfei Li, Pingping Zhang, Qingqiang Yao

Abstract readReview
In one paragraph

Review in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Biomimetic Cell Membrane-Coated MOFs System for Targeted Cancer Therapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  12. Article
  13. Article
  14. Thermally Gated Dual-Cascade Nanozyme for Enhanced Mild-Temperature Photothermal Therapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Qiuxiang WangInstitute of Materia Medica, Shandong First Medical University & Shandong Academy of Medical Sciences Jinan 250062 Shandong China pingpingzhang6087@163.com +86-0531-82919706 +86-0531-82919706.
Yue SunInstitute of Materia Medica, Shandong First Medical University & Shandong Academy of Medical Sciences Jinan 250062 Shandong China pingpingzhang6087@163.com +86-0531-82919706 +86-0531-82919706.
Shangfei LiInstitute of Materia Medica, Shandong First Medical University & Shandong Academy of Medical Sciences Jinan 250062 Shandong China pingpingzhang6087@163.com +86-0531-82919706 +86-0531-82919706.
Pingping ZhangInstitute of Materia Medica, Shandong First Medical University & Shandong Academy of Medical Sciences Jinan 250062 Shandong China pingpingzhang6087@163.com +86-0531-82919706 +86-0531-82919706.ORCID https://orcid.org/0000-0003-2603-2855
Qingqiang YaoInstitute of Materia Medica, Shandong First Medical University & Shandong Academy of Medical Sciences Jinan 250062 Shandong China pingpingzhang6087@163.com +86-0531-82919706 +86-0531-82919706.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metal-organic frameworks have the properties of high porosity, variable pore sizes, and easy modification as drug delivery systems. In particular, ZIF-8 based on Zn

Identifiers

PMID35515141
PMCPMC9057214

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.